Ottawa Heart Institute Research Corporation
Clinical trials sponsored by Ottawa Heart Institute Research Corporation, explained in plain language.
-
Heart procedure patients face critical choice: blood thinner or aspirin?
Disease control CompletedThis study compared two approaches to prevent strokes in people with atrial fibrillation who had successful heart ablation procedures. Researchers tested whether a daily blood thinner (rivaroxaban) works better than daily aspirin at preventing strokes and silent brain injuries ov…
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Heart drugs tested as potential COVID-19 lifesaver
Disease control CompletedThis international study investigated whether starting common blood pressure medications (ACE inhibitors or ARBs) could help high-risk COVID-19 patients. Researchers enrolled 372 hospitalized and outpatient adults who tested positive for COVID-19 and weren't already taking these …
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Can a virtual workout boost health for women with heart implants?
Symptom relief CompletedThis small pilot study tested whether two types of virtual exercise programs are safe and practical for women who have pacemakers or similar heart devices. Researchers compared a high-intensity interval training (HIIT) program to a standard moderate-intensity program over 12 week…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Apr 02, 2026 02:42 UTC